Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
CN	B	CN102597771	Oct 05, 2010	Patent	Grant
Type : Patent Sub-Type : Grant
GRANTED PATENT FOR INVENTION		For redirecting antibody specific high-affinity adapter molecule		Aug 31, 2016
KR	A	KR20120096466	Oct 05, 2010	Patent	Application
Type : Patent Sub-Type : Application
UNEXAMINED PATENT APPLICATION		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Aug 30, 2012
WO	A2	WO2011044133	Oct 05, 2010	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITHOUT INTERNATIONAL SEARCH REPORT or INTERNATIONAL APPLICATION PUBLISHED WITH DECLARATION UNDER ARTICLE 17 (2) (A)		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Apr 14, 2011
AU	B2	AU2010303636	Oct 05, 2010	Patent	Grant
Type : Patent Sub-Type : Grant
PATENT PROCEEDED BY OPI		High affinity adaptor molecules for redirecting antibody specifity		Sep 15, 2016
CA	A1	CA2775765	Oct 05, 2010	Patent	Application
Type : Patent Sub-Type : Application
APPLICATION LAID OPEN		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Apr 14, 2011
JP	A	JP2013506435	Oct 05, 2010	Patent	Application
Type : Patent Sub-Type : Application
Published unexamined patent application		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Feb 28, 2013
EP	A2	EP2486408	Oct 05, 2010	Patent	Application
Type : Patent Sub-Type : Application
APPLICATION PUBLISHED WITHOUT SEARCH REPORT		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Aug 15, 2012
US	A1	US20160251400	Feb 02, 2016	Patent	Application
Type : Patent Sub-Type : Application
FIRST PUBLISHED PATENT APPLICATION		HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY		Sep 01, 2016
JP	A	JP2016163565	Feb 22, 2016	Patent	Application
Type : Patent Sub-Type : Application
Published unexamined patent application		抗体特異性をリダイレクトするための高親和性アダプター分子		Sep 08, 2016

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
OPSONIC THERAPEUTICS INC	225 CEDAR HILL ROAD SUITE 200-1 MARLBOROUGH MA 01752

International Classification(s)

• C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF
• C40B:COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL ....

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Collinson, Albert	Marlborough, US	8	61
# of filed Patents : 8 Total Citations : 61
Kamen, Robert	Sudbury, US	8	172
# of filed Patents : 8 Total Citations : 172
Sällberg, Matti	Stockholm, SE	24	49
# of filed Patents : 24 Total Citations : 49
Schürmann, Gregor	Hannover, DE	2	1
# of filed Patents : 2 Total Citations : 1
Vahlne, Anders	Stockholm, SE	31	154
# of filed Patents : 31 Total Citations : 154
Wagner, Peter	Braunschweig, DE	213	4270
# of filed Patents : 213 Total Citations : 4270

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• C12N Class

• 0 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Sep 15, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
March 15, 2016	US,9284548,B2   US9284548B2	GRANTED PATENT AS SECOND PUBLICATION
October 25, 2012	US,20120271033,A1   US20120271033A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9284548

High affinity adaptor molecules for redirecting antibody specifity

---

Abstract

---

Disclosed are methods for identifying high affinity adaptor molecules that bind to both a circulating antibody and a target molecule and redirect the specificity of the circulating antibody to the target molecule. Exemplary high affinity adaptor molecules are also provided.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• LAPS2020
• STCH2020
• FP2020
• FEPP2019
• CC2016
• I2016
• STCF2016
• P2012
• AS2012
• F2010
• PD2009

Date	Code	Event	Description
Apr 20, 2020	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES	free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY
Apr 20, 2020	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Mar 15, 2020	FP	EXPIRED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Mar 15, 2020
Nov 04, 2019	FEPP	FEE PAYMENT PROCEDURE	free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY
Dec 13, 2016	CC	CERTIFICATE OF CORRECTION
Mar 15, 2016	I	Issuance
Feb 24, 2016	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Oct 25, 2012	P	Published
Jul 25, 2012	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COLLINSON, ALBERT;WAGNER, PETER;SALLBERG, MATTI;AND OTHERS;SIGNING DATES FROM 20120702 TO 20120708;REEL/FRAME:028638/0434 Owner name: OPSONIC THERAPEUTICS INC., MASSACHUSETTS
Oct 05, 2010	F	Filing
Oct 05, 2009	PD	Priority Date